UBS Group’s Immuron IMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $385 | Buy |
+363
| New | +$362 | ﹤0.01% | 9882 |
|
|
2026
Q1 | – | Sell |
-4,143
| Closed | -$3.16K | – | 10812 |
|
|
2025
Q4 | $3.16K | Buy |
4,143
+2,277
| +122% | +$3.75K | ﹤0.01% | 9089 |
|
|
2025
Q3 | $3.54K | Sell |
1,866
-14,429
| -89% | -$25.8K | ﹤0.01% | 9034 |
|
|
2025
Q2 | $28.4K | Buy |
+16,295
| New | +$29.1K | ﹤0.01% | 8204 |
|
|
2024
Q3 | – | Sell |
-163
| Closed | -$394 | – | 9765 |
|
|
2024
Q2 | $394 | Sell |
163
-913
| -85% | -$2.22K | ﹤0.01% | 8942 |
|
|
2024
Q1 | $2.83K | Buy |
+1,076
| New | +$2.31K | ﹤0.01% | 7821 |
|
|
2023
Q2 | – | Sell |
-197
| Closed | -$369 | – | 9233 |
|
|
2023
Q1 | $369 | Sell |
197
-2,164
| -92% | -$4.37K | ﹤0.01% | 9058 |
|
|
2022
Q4 | $4.91K | Buy |
+2,361
| New | +$4.72K | ﹤0.01% | 9252 |
|
|
2022
Q2 | – | Sell |
-2,261
| Closed | -$8K | – | 10602 |
|
|
2022
Q1 | $8K | Sell |
2,261
-145
| -6% | -$467 | ﹤0.01% | 8670 |
|
|
2021
Q4 | $6K | Buy |
2,406
+563
| +31% | +$1.9K | ﹤0.01% | 9275 |
|
|
2021
Q3 | $7K | Buy |
1,843
+1,451
| +370% | +$6.13K | ﹤0.01% | 8310 |
|
|
2021
Q2 | $2K | Buy |
392
+200
| +104% | +$1.07K | ﹤0.01% | 8952 |
|
|
2021
Q1 | $1K | Sell |
192
-1,935
| -91% | -$13.3K | ﹤0.01% | 8775 |
|
|
2020
Q4 | $14K | Buy |
2,127
+637
| +43% | +$4.56K | ﹤0.01% | 7216 |
|
|
2020
Q3 | $11K | Buy |
+1,490
| New | +$13.5K | ﹤0.01% | 6765 |
|
|
2020
Q2 | – | Sell |
-3,297
| Closed | -$6K | – | 8138 |
|
|
2020
Q1 | $6K | Buy |
+3,297
| New | +$10.4K | ﹤0.01% | 7220 |
|
|
2019
Q4 | – | Sell |
-2,019
| Closed | -$6K | – | 8255 |
|
|
2019
Q3 | $6K | Buy |
2,019
+1,845
| +1,060% | +$5.53K | ﹤0.01% | 7411 |
|
|
2019
Q2 | $1K | Sell |
174
-304
| -64% | -$1.39K | ﹤0.01% | 7716 |
|
|
2019
Q1 | $3K | Sell |
478
-598
| -56% | -$4.31K | ﹤0.01% | 7335 |
|
|
2018
Q4 | $6K | Sell |
1,076
-1,107
| -51% | -$8.49K | ﹤0.01% | 7478 |
|
|
2018
Q3 | $20K | Buy |
2,183
+829
| +61% | +$8.37K | ﹤0.01% | 6792 |
|
|
2018
Q2 | $14K | Sell |
1,354
-2,394
| -64% | -$22.9K | ﹤0.01% | 6938 |
|
|
2018
Q1 | $43K | Buy |
3,748
+2,948
| +369% | +$25.4K | ﹤0.01% | 5830 |
|
|
2017
Q4 | $4K | Buy |
800
+109
| +16% | +$575 | ﹤0.01% | 7467 |
|
|
2017
Q3 | $4K | Sell |
691
-516
| -43% | -$3.1K | ﹤0.01% | 7310 |
|
|
2017
Q2 | $10K | Buy |
+1,207
| New | +$10.3K | ﹤0.01% | 6771 |
|
Other funds holding IMRN
UBS Group's IMRN Position: Q2 2026 in Review
UBS Group opened a new position in Immuron (IMRN) in Q2 2026: 363 shares worth $385. The stake represents ﹤0.01% of the portfolio and ranks #9882 among its holdings. This is a return to the name: UBS Group previously reported a position in IMRN as recently as Q4 2025.
UBS Group first reported a position in IMRN in Q2 2017 and has held it in 26 quarters since. The position peaked at $43K in Q1 2018. 4 funds tracked by Wall St. Rank hold IMRN as of Q2 2026.
- UBS Group held 363 shares of Immuron worth $385 as of Q2 2026.
- Immuron was a new UBS Group position in Q2 2026.
- Immuron made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9882 holding.
- UBS Group first reported a position in Immuron in Q2 2017 and has held it in 26 quarters since.
- UBS Group's Immuron position peaked at $43K in Q1 2018.
- 4 funds tracked by Wall St. Rank held Immuron as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.